21-Nov-2024 3:05 PM CST - Business Wire Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at two upcoming investor conferences: Citi's 2024 Global Healthcare Conference Fireside Chat: Tuesday, December 3, 2024 at 10:15 a.m. Eastern Time in Miami, FL 7th Annual Evercore HealthCONx Conference Fireside Chat: Wednesday, December 4, 2024 at 2:35 p.m. Eastern Time in Coral Gables, FL Live webcasts of each fireside chat will be accessible on the companys website, Acadia.com, und
6-Nov-2024 3:05 PM CST - Business Wire Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the third quarter ended September 30, 2024. The success of Acadias two growing commercial franchises is clearly reflected in our third quarter 2024 results, where we delivered $250.4 million in total revenues, putting us on track to reach an impressive milestone of more than $1 billion in annualized sales in 2025, said Catherine Owen Adams, Chief Executive Officer. In my new role
17-Oct-2024 5:41 PM CST - Business Wire Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024 Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Wednesday, November 6, 2024, after the close of the U.S. financial markets. Acadias management team will also host a conference call and webcast on November 6, 2024, at 4:30 p.m. Eastern Time to discuss financial results and operations. The conference call will be available on Acadias website, Acadia.com under the investors section and will be archived
21-Nov-2024 3:05 PM CST - Business Wire Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at two upcoming investor conferences: Citi's 2024 Global Healthcare Conference Fireside Chat: Tuesday, December 3, 2024 at 10:15 a.m. Eastern Time in Miami, FL 7th Annual Evercore HealthCONx Conference Fireside Chat: Wednesday, December 4, 2024 at 2:35 p.m. Eastern Time in Coral Gables, FL Live webcasts of each fireside chat will be accessible on the companys website, Acadia.com, und
6-Nov-2024 3:05 PM CST - Business Wire Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the third quarter ended September 30, 2024. The success of Acadias two growing commercial franchises is clearly reflected in our third quarter 2024 results, where we delivered $250.4 million in total revenues, putting us on track to reach an impressive milestone of more than $1 billion in annualized sales in 2025, said Catherine Owen Adams, Chief Executive Officer. In my new role
17-Oct-2024 5:41 PM CST - Business Wire Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024 Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Wednesday, November 6, 2024, after the close of the U.S. financial markets. Acadias management team will also host a conference call and webcast on November 6, 2024, at 4:30 p.m. Eastern Time to discuss financial results and operations. The conference call will be available on Acadias website, Acadia.com under the investors section and will be archived
